Erasca【ERAS】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.56

買値

1.55

売値

1.70

出来高

1,813,667

1.53 日の範囲 1.7599

1.51 52 週間の範囲 3.45

時価総額

441.055M

前日終値

1.63

始値

1.69

時刻

400

1.56

(formt)

最終取引時間

財務取引量

US$ 2,924,869

VWAP

1.6127

平均取引量 (3 か月)

1,353,148

発行済株式数

282,727,282

配当利回り

PER

-3.55

1 株当たり利益 (EPS)

-0.44

歳入

純利益

-125.04M

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.erasca.com

本社

Wilmington, Delaware, USA

設立

Erasca Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ERAS. The last closing price for Erasca was US$1.63. Over the last year, Erasca shares have traded in a share price range of US$ 1.51 to US$ 3.45.

Erasca currently has 282,727,282 shares in issue. The market capitalisation of Erasca is US$460.85 million. Erasca has a price to earnings ratio (PE ratio) of -3.55.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.11	-6.58682634731	1.67	1.7192	1.51	1446130	1.6040801	CS
4	-0.33	-17.4603174603	1.89	2.11	1.51	1315856	1.76851925	CS
12	-1.07	-40.6844106464	2.63	3.3	1.51	1353148	2.33320907	CS
26	-1.03	-39.7683397683	2.59	3.305	1.51	1645742	2.64446554	CS
52	-0.16	-9.3023255814	1.72	3.45	1.51	1670696	2.54249234	CS
156	-10.78	-87.358184765	12.34	12.8	1.51	1073321	3.51271273	CS
260	-14.34	-90.1886792453	15.9	24.47	1.51	978820	4.56367214	CS

ERAS - Frequently Asked Questions (FAQ)

What is the current Erasca share price?

The current share price of Erasca is US$ 1.56

How many Erasca shares are in issue?

Erasca has 282,727,282 shares in issue

What is the market cap of Erasca?

The market capitalisation of Erasca is USD 460.85M

What is the 1 year trading range for Erasca share price?

Erasca has traded in the range of US$ 1.51 to US$ 3.45 during the past year

What is the PE ratio of Erasca?

The price to earnings ratio of Erasca is -3.55

What is the reporting currency for Erasca?

Erasca reports financial results in USD

What is the latest annual profit for Erasca?

The latest annual profit of Erasca is USD -125.04M

What is the registered address of Erasca?

The registered address for Erasca is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Erasca website address?

The website address for Erasca is www.erasca.com

Which industry sector does Erasca operate in?

Erasca operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
JTAIJet AI Inc	US$ 6.02 (133.33%)	101.64M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	248.48M
WRDWeRide Inc	US$ 31.4877 (83.39%)	20.57M
INLFINLIF Limited	US$ 16.27 (80.58%)	7.67M
MBRXMoleculin Biotech Inc	US$ 2.1201 (66.94%)	134.88M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3.08 (-56.31%)	425.19k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	US$ 19.0001 (-49.58%)	1.01M
NEXNNexxen International Ltd	US$ 10.30 (-49.16%)	160.99k
BSLKBolt Projects Holdings Inc	US$ 0.6626 (-46.13%)	13.07M
CNSPCNS Pharmaceuticals Inc	US$ 0.1415 (31.26%)	480.49M
MGOLMGO Global Inc	US$ 0.7176 (-15.08%)	411.17M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	248.48M
INTCIntel Corporation	US$ 23.60 (-2.20%)	225.04M
NVDANVIDIA Corporation	US$ 138.85 (2.63%)	189.56M